Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWAP-2: Switching Ticagrelor to Prasugrel in Stable CAD
NCT01587651Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of prasugrel in coronary artery disease (CAD), sponsored by Daiichi Sankyo Co., Ltd.. Started Mar 2012; status: completed.
02
Drugs
prasugrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01587651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01587651.